1-2 of 2
Lila-Sabrina Fetita
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluating the safety and tolerability of switching from emicizumab to fitusiran prophylaxis in adult males with severe hemophilia A, with or without inhibitors: SWITCH study, a trial in progress

Free
Guy Young, Chanchala Kaddi, Shariq Ali, Lila-Sabrina Fetita, Ekta Seth Chhabra, Marek Demissie, Sheng-Chieh Chou
Journal: Blood
Blood (2025) 146 (Supplement 1): 3076.
https://doi.org/10.1182/blood-2025-3076
Published: 2025
Journal Articles

High treatment compliance and tolerability with fitusiran antithrombin-based dose regimen in people with hemophilia A or B, with or without inhibitors: ATLAS-OLE study

Free
Mindy Simpson, Chia-Yau Chang, Kaan Kavakli, Steven Pipe, Jing Sun, Chur-Woo You, Lila-Sabrina Fetita, Abhimanyu Yarramaneni, Chuanwu Zhang, Sandra Casiano, Arta Subagiarta, Erin Cockrell
Journal: Blood
Blood (2025) 146 (Supplement 1): 1298.
https://doi.org/10.1182/blood-2025-1298
Published: 2025